Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfreundschuh

Showing results (131-140 of 260) with videos related to

Pageof 26
Sort By:
Molecular Immunology|December 1, 1994
Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sourcesW Jung, S Krueger, C Renner, et al.
Leukemia & Lymphoma|December 1, 1994
Impaired antibody levels to tetanus toxoid and pneumococcal polysaccharides in acute leukemiasD Spickermann, A Gause, M Pfreundschuh, et al.
Cancer Research|November 1, 1990
Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibodyU Sahin, F Hartmann, P Senter, et al.
Cancer Research|April 23, 1999
Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivoS Bauer, C Renner, J P Juwana, et al.
Blood|July 1, 1996
T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28C Renner, S Ohnesorge, G Held, et al.
Immunobiology|June 1, 1997
Role of naive and memory T cells in tumor cell lysis mediated by bi-specific antibodiesC Renner, G Held, S Ohnesorge, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1997
Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cellsC Renner, G Held, S Ohnesorge, et al.
British Journal of Haematology|March 22, 2001
MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studiesM Küpper, S Joos, F von Bonin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Single cell PCR for the analysis of Hodgkin's disease: four years laterM Küpper, U Loftin, F von Bonin, et al.
Cancer Research|May 15, 1990
Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in miceA Engert, G Martin, M Pfreundschuh, et al.
Pageof 26

Showing results (131-140 of 260) with videos related to

Sort By:
Pageof 26
Molecular Immunology|December 1, 1994
Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sourcesW Jung, S Krueger, C Renner, et al.
Leukemia & Lymphoma|December 1, 1994
Impaired antibody levels to tetanus toxoid and pneumococcal polysaccharides in acute leukemiasD Spickermann, A Gause, M Pfreundschuh, et al.
Cancer Research|November 1, 1990
Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibodyU Sahin, F Hartmann, P Senter, et al.
Cancer Research|April 23, 1999
Immunotherapy of human tumors with T-cell-activating bispecific antibodies: stimulation of cytotoxic pathways in vivoS Bauer, C Renner, J P Juwana, et al.
Blood|July 1, 1996
T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28C Renner, S Ohnesorge, G Held, et al.
Immunobiology|June 1, 1997
Role of naive and memory T cells in tumor cell lysis mediated by bi-specific antibodiesC Renner, G Held, S Ohnesorge, et al.
Cancer Immunology, Immunotherapy : CII|April 1, 1997
Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cellsC Renner, G Held, S Ohnesorge, et al.
British Journal of Haematology|March 22, 2001
MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed-Sternberg cells: results from single-cell polymerase chain reaction and molecular cytogenetic studiesM Küpper, S Joos, F von Bonin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Single cell PCR for the analysis of Hodgkin's disease: four years laterM Küpper, U Loftin, F von Bonin, et al.
Cancer Research|May 15, 1990
Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in miceA Engert, G Martin, M Pfreundschuh, et al.
Pageof 26